Opioid

Problematic opioid use in Ireland, 2015–2019

Published by
Health Research Board

In this report, the Health Research Board presents the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. 

Key Findings:

In total, there were an estimated 19,875 problematic opioid users in Ireland in 2019

The majority of problematic opioid users were male (72.3%) 

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

Citation
Day, N., Wass, M. & Smith, K. Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes. Addict Sci Clin Pract 17, 40 (2022). https://doi.org/10.1186/s13722-022-00323-4
Publication Date

Abstract

Background

Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment demands and limited childcare options reduce treatment opportunities for clients. A completely virtual model of care has been developed in Alberta, Canada.

The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis

Citation
Dickson-Gomez, J., Krechel, S., Spector, A. et al. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis. Subst Abuse Treat Prev Policy 17, 55 (2022). https://doi.org/10.1186/s13011-022-00480-4
Publication Date

Background

Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis.

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Citation
Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial. Drug and Alcohol Dependence Reports, 3, 100045.

Abstract

Background

Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and acceptability of MySafeRx, a mobile platform integrating motivational coaching, adherence monitoring, and electronic dispensing during office-based B/N treatment.

Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study

Citation
Rempala, H.A., Barterian, J.A. Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study. Subst Abuse Treat Prev Policy 17, 28 (2022). https://doi.org/10.1186/s13011-022-00458-2
Publication Date

Background

When used in combination with other therapies for drug use disorders, neurofeedback (NF) has been classified as "probably effective," according to recent research in the community of people with opioid use disorder.

The International Narcotics Research Conference (INRC)

Valencia,

The I.N.R.C. will resume its in person meetings from July 4th to 8th 2022 in Valencia, Spain.

The International Narcotics Research Conference (INRC) is an international forum for pre-clinical and clinical researchers to strengthen our knowledge of opioid pharmacology and function.

Methadone maintenance treatment

Published by
Ministerio de Salud y Protección Social de Colombia
Publication Date

Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment, as well as recommendations in public health for the strengthening of these programs.

Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017

Citation
Bounthavong, M., Suh, K., Li, M. et al. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Subst Abuse Treat Prev Policy 16, 80 (2021). https://doi.org/10.1186/s13011-021-00415-5
Publication Date

One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were diagnosed with opioid use disorder. In 2019, 49,860 drug overdose deaths (70.6 percent of all drug overdose deaths) were caused by opioid use and abuse.